HomeASBPW • NASDAQ
add
Aspire Biopharma Holdings Inc.
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.43M | 517.06% |
Net income | -15.94M | -6,801.90% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.35M | 11,950.68% |
Total assets | 1.97M | — |
Total liabilities | 8.92M | — |
Total equity | -6.95M | — |
Shares outstanding | 48.90M | — |
Price to book | -0.50 | — |
Return on assets | -337.17% | — |
Return on capital | 1,543.07% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -15.94M | -6,801.90% |
Cash from operations | -1.75M | -807.66% |
Cash from investing | — | — |
Cash from financing | 3.09M | 1,250.79% |
Net change in cash | 1.34M | 3,618.63% |
Free cash flow | 14.27M | — |
About
Founded
2021
Website
